Accepted Regular Abstracts

33.Coronary revascularization/PCI (DES)
Receipt no.First nameLast nameAbstract title
10105IppeiWatanabeComparison of the Efficacy between First and Second Generation-Drug Eluting Stent for Coronary Bifurcation in Patients with Angina
10358MasanobuOhyaLong-term (7-year) Clinical Outcomes after Biodegradable Polymer-based Biomatrix Biolimus-eluting Stent Implantation
10557HirofumiSugiyamaLong-Term Clinical Outcomes after Everolimus-Eluting Coronary Stent Implantation
10739MasayukiMoriEarly Endothelialization of Biolimus A9 with Bioresorbable Polymer Stent (Nobori®) in Porcine Coronary Model
10794YusukeAdachiDeterminants of Left Ventricular Ejection Fraction Improvement following Coronary Artery Revascularization in Ischemic Heart Failure
10795TakashiUnokiVascular Endothelial Growth Factor Levels Associated with the Risk of Major Adverse Cardiac and Cerebrovascular Events After Drug-eluting Stent Implantation
10831NaokiMoriComparison of 2-year Clinical Outcomes between Long Single Stent and Overlapping Double Stent with Everolimus-Eluting Stents for Similar Long Lesions
10856YohsukeHondaDid all Bleeding events after DES implantation to be associated with poor prognosis?
10881TakahiroTokudaLong Term Clinical Outcomes after Second Generation DES Implantation in Real World.
10921DaisukeUeshimaEffect of Over-2-Year Dual Antiplatelet Therapy on the Rate of Major Cardiac and Cerebral Adverse Events for Everolimus-Eluting Stent Implantation
10925DaisukeUeshimaTreatment for Hyperlipidemia Can Reduce Both Major Adverse Cardiac and Cerebral Events and Major Bleeding in Triple antithrombotic therapy
10940MasahiroToyamaIntra-Stent Thrombus Early After Stent Implantation is Associated With Cytochrome P450 2C19 Genotypes
11126HiromichiTamekiyoLong-term Course of Angiographic Late Acquired Peri-stent Contrast Staining (LAPSS) after Sirolimus-Eluting Stent (SES) Implantation.
11165HirotoSuzuyamaImpact of an excellent long term outcome after 2nd generation DES implantation for unprotected left main coronary artery bifurcation lesion
11166TakeshiTadaClinical Predictors of Progressive Peri-stent Contrast Staining
11203NaofumiAnjoLDL/HDL ratio predicts the rate of uncovered stent strut evaluated by optical coherence tomography
11249ShunjiYoshikawaFour-year Clinical Outcome of Everolimus-eluting Stent Implantation in Patients with Acute Coronary Syndrome: Investigation from Tokyo-MD PCI Multicenter Registry
11254GoroYoshioka"Full-metal jacket" stenting of drug eluting stent in 2-year follow-up
11256ShunjiYoshikawaSerial Optical Coherence Tomography Assessment of Vascular Healing after Everolimus-eluting Stent Implantation in Acute Coronary Syndrome and Stable Angina Pectoris
11294YoheiYakutaThe Initial and Late Followed Results of Drug-Eluting Stent for Small Target Vessels: Comparison between Xience, Promus and Resolute-Integrity Stent.　
11337ToruMiyazakiFour-Year Outcomes in Patients with Renal Dysfunction After Everolimus-eluting Stent Implantation: Results from Multicenter Tokyo-MD PCI Study
11341ToruMiyazakiImpact of Renal Dysfunction on Clinical Outcomes with Everolimus-eluting Stents in Patients with Stable Angina: Results from Tokyo-MD PCI Study
11344TadateruTakayamaComparision of aspirin-rivaroxaban combination therapy versus dual antiplatelet therapy for coronary in-stent re-endothelialization and in swains with drug-eluting stent deployment
11352TakashiHiromasaImpact of Total Stent Length After Sirolimus-Eluting Stent Implantation on 7-Year Clinical Outcomes
11357NaotakaAkutsuComparison of neointimal feature between SYNERGY® and PROMUS® observed by serial angioscopy and optical coherence tomography –the SYNERGY® pilot study-
11389YuichirouSagawaThe predictors of in–stent restenosis after everolimus–eluting stent implantation in patients on hemodialysis
11565ToruMiyoshiNeointimal quality, not quantity determines stent thrombogenecity after first and second generation drug-eluting stent implantation by chronic angioscopic study
11587YuzoKagawaAngiographic and Clinical Outcomes of Second-Generation Drug-Eluting Stents in Patients on Hemodialysis
11588HiroshiTakeshimaImpact of Chronic High-sensitive C-reactive Protein Levels on In-stent Restenosis in Patients Treated with XIENCE Stent
11796YohsukeHondaPredictors of bleeding events after DES implantation differ depending on the time period
11833NoriakiTabataClinical Impact of Cancer on Adverse Cardiovascular Events after Percutaneous Coronary Intervention
12214KatsuyaMiuraTen-year Clinical Outcomes After The First Sirolimus-eluting Stent Implantation: Impact of In-stent Restenosis Lesion
12243HidekiYanoTwo (or four)-week interval optical coherence tomography: imaging evidence on neointimal coverage completion after implantation of the Xience Everolimus-eluting stent.
12396RyutaSugiharaClinical Outcomes after Second Generation Drug-Eluting Stent Implantation at Right Coronary Artery Ostial Lesions, Compared with First Generation Drug-Eluting Stent.
12688YuzoKagawaLong-term Angiographic Outcome of Sirolimus-eluting Stent and Everolimus-eluting Stent
12744HidekiKitaharaPredictors of 5-Year Target Lesion Revascularization after Second Generation Drug-Eluting Stent Implantation: Intravascular Ultrasound and Angiographic Analyses
12818HidekiKitaharaStent Oversizing Improves Acute and Long-Term Outcomes after Drug-Eluting Stent Implantation in De Novo Coronary Lesions
12861TakeshiIjichiComparisons of Vascular Reaction between Biodegradable Polymer Based Sirolimus and Permanent Polymer Based Everolimus Eluting Stents in Porcine Coronary Artery
13212YujiMurakamiPlatelet reactivity and clinical outcome after coronary drug-eluting stent implantation: a prospective single-center registry study
13229MasashiYokoiLong-term clinical results after first generation drug-eluting stent implantation
13322TatsuyukiSatoImpact of Prolonged Dual Antiplatelet Therapy on Ten-year Outcomes Following Drug-eluting Stent Implantation
13349MaotoHabaraImpact of Diabetes Mellitus for Angiographical Mid-term Outcome in New Generation Drug Eluting Stent
13378MasashiYokoiImpact of first generation drug-eluting stents on the long-term clinical results compared with bare-metal stent
13391YutakaGoryoNeointimal Condition after Second Generation Drug Eluting Stent Implantation is not Affected by Prolonged Dual Antiplatelet Therapy
13409YuheiYamajiImpact of Renal Dysfunction on Very Long-Term(7 to 10 Years) Clinical Outcomes After Sirolimus-Eluting Stent Implantation.
13456MakotoWatanabeDifference in Neointimal Proliferation after Thin- and Thick-Strut Drug Eluting Stents Implantation in Coronary Bifurcation Lesion: an OCT study
13703TakenobuShimadaPredictors of Midterm Restenosis in Very Small Vessel Lesions After Treatment With 2.25 mm Drug-Eluting Stents
13744MasakazuTsutsumiLong-term Outcomes of First and Second Generation Drug-eluting Stent Implantation for Ostial Lesion of Left Main Coronary Artery.
20078Kyung HwanKimDirect Comparison of Biodegradable Biolimus-eluting Stent Versus Durable Everolimus-eluting Stent: An Updated Meta-analysis

PAGE TOP